Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on GalNAc L96. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117384226B details a high-purity GalNAc synthesis route offering significant cost reduction and supply chain reliability for oligonucleotide drug manufacturing.